Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration

Published:2015-01 Issue:1 Volume:122 Page:138-145
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Jackson Timothy L.,Chakravarthy Usha,Slakter Jason S.,Muldrew Alyson,Shusterman E. Mark,O'Shaughnessy Denis,Arnoldussen Mark,Gertner Michael E.,Danielson Linda,Moshfeghi Darius M.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference22 articles.

1. The estimated prevalence and incidence of late stage age-related macular degeneration in the UK;Owen;Br J Ophthalmol,2012

2. SEE Study Team. Causes of blindness and visual impairment in a population of older Americans: the Salisbury Eye Evaluation Study;Munoz;Arch Ophthalmol,2000

3. Prevalence and causes of registered blindness in the largest federal state of Germany;Finger;Br J Ophthalmol,2011

4. Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008;Bunce;Eye (Lond),2010

5. VIEW 1 and VIEW 2 Study Groups. Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration;Heier;Ophthalmology,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial;The Lancet;2024-07

2. Persistent and Poor-Responsive Cystoid Macular Edema after Stereotactic Radiotherapy in Neovascular Age-Related Macular Degeneration: A Case Report of Three Patients;Klinische Monatsblätter für Augenheilkunde;2024-04

3. Real-world experience of using stereotactic radiotherapy combined with anti-vascular endothelial growth factor to treat neovascular AMD;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-03-06

4. Gamma radiation coupled ADP-ribosyl transferase activity of Pseudomonas aeruginosa PE24 moiety;Applied Microbiology and Biotechnology;2023-02-18

5. Two-year outcomes of episcleral brachytherapy adjunct to anti-VEGF therapy for treatment-resistant nAMD;Graefe's Archive for Clinical and Experimental Ophthalmology;2022-06-17